Objective In this study, we aimed to compare clinical outcomes of superior transseptal
approach with the conventional left atriotomy in patients undergoing mitral valve
surgery.Methods Between January 2010 and November 2012, a total of 91 consecutive adult patients
(39 males, 52 females; mean age: 54.0±15.4 years; range, 16 to 82 years) who
underwent mitral valve surgery in the Division of Cardiovascular Surgery at
Koşuyolu Training Hospital were included. The patients were randomized to either
superior transseptal approach (n=47) or conventional left atriotomy (n=44).
Demographic characteristics of the patients, comorbidities, additional
interventions, intraoperational data, pre- and postoperative electrophysiological
study findings, and postoperative complications were recorded.Results Of all patients, 86.7% (n=79) were in New York Heart Association Class III, while
12 were in New York Heart Association Class IV. All patients underwent
annuloplasty (42.9%) or valve replacement surgery (57.1%). There was no
significant difference in pre- and postoperative electrocardiogram findings
between the groups. Change from baseline in the cardiac rhythm was statistically
significant in superior transseptal approach group alone
(P<0.001). There was no statistically significant difference
in mortality rate between the groups. Permanent pacemaker implantation was
performed in 10.6% of the patients in superior transseptal approach group and 4.5%
in the conventional left atriotomy group. No statistically significant difference
in bleeding, total length of hospital and intensive care unit stay, the presence
of low cardiac output syndrome was observed between the groups.Conclusion Our study results suggest that superior transseptal approach does not lead to
serious or fatal adverse effects on sinus node function or atrial vulnerability,
compared to conventional approach.